Immuron North American Travelan® Sales Up 95%, Global Sales Up 60%
Immuron Limited - American Depositary Shares (IMRN)
US:NASDAQ Investor Relations:
immuron.com/investor-centre/business-overview
Company Research
Source: GlobeNewswire
Key Highlights: North American sales up by 95% YoY in Q3 FY20Immuron achieved 60% YoY growth in worldwide product sales in Q3 FY20.YTD March 31, FY20 worldwide sales reached AU $2.67M, increasing 57% YoY.In Australia, Q3 FY20 gross sales grew by 35% YoY to $475K.In the USA, Q3 FY20 gross sales increased by 50% YoY to AU $412K.In Canada, Q3 FY20 sales reached $96K. MELBOURNE, Australia, April 20, 2020 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the treatment of gut mediated diseases, today announced the sales results of its commercially available and over-the-counter gastrointestinal and digestive health immune supplement Travelan® for the third quarter of the fiscal year 2020 ending on March 31, 2020. North American Travelan® sales were up by 95% and worldwide product sales grew by 60% YoY in the third quarter of FY20, reaching AU $983K* compared to AU $6
Show less
Read more
Impact Snapshot
Event Time:
IMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMRN alerts
High impacting Immuron Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMRN
News
- Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap EventGlobeNewswire
- Immuron Limited to Present at November 21st Virtual Investor Summit Microcap EventAccesswire
- Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare ConferenceGlobeNewswire
- Immuron Travelan® continued strong sales growthGlobeNewswire
- NMRC Reports Results for Campylobacter Controlled Human Infection Model StudyGlobeNewswire
IMRN
Sec Filings
- 11/18/24 - Form 6-K
- 11/14/24 - Form 6-K
- 10/29/24 - Form 6-K
- IMRN's page on the SEC website